- Cohesive ophthalmic viscoelastic devices (OVD)
- Dispersive ophthalmic viscoelastic devices (OVD)
Ophthalmic Viscoelastic Devices (OVDs) Market Size was valued at $2,341 million in 2022 and is expected to grow $3,227 million by 2029 growing at a significant 4.14% from 2023-2029. Ophthalmic Viscoelastic Devices (OVDs) Market in a variety of eye surgeries, including cataract surgery, glaucoma surgery, and others. These devices help to protect the fragile ocular tissues by producing pressure in the anterior chamber, compartmentalising inside the eye, and allowing patients to have a speedier and safer surgery with a faster recovery. Depending on the situation, ophthalmologists use a variety of ophthalmic instruments. As a result, ophthalmic viscoelastic devices serve a critical role in the treatment of various eye diseases during surgery all over the world. Ophthalmic viscoelastic devices (OVDs) are the medical devices that are used in the cataract surgery in order to create and maintain the space in the anterior chamber of the eye during phacoemulsification and implantation of an intraocular lens (IOL). There are various types of the ophthalmic viscoelastic devices such as dispersive ophthalmic viscoelastic device and cohesive ophthalmic viscoelastic device. Most of the ophthalmic viscoelastic devices (OVDs) contain sodium hyaluronate (NaHA) or hydroxypropyl methylcellulose (HPMC). The surge in government initiatives aimed at establishing rules to control the global increase in vision impairment is pressuring major manufacturers to release new ophthalmic products. Other factors that contribute to the growth of the Ophthalmic Viscoelastic Devices (OVDs) Market include an increase in the prevalence of cataracts and glaucoma, an increase in the number of eye procedures performed, and an increase in the geriatric population. The Ophthalmic Viscoelastic Devices Market is also expected to rise due to an increase in the adoption of viscoelastic devices around the world.
Ophthalmic Viscoelastic Devices (OVDs) Market Summary
Study Period
2024-2030Base Year
2023CAGR
4.14%Largest Market
North AmericaFastest Growing Market
Asia-PacificOphthalmic Viscoelastic Devices (OVDs) Market Dynamics
Increase in the prevalence of eye diseases and rise in the number of cataract and glaucoma surgeries are driving the growth of ophthalmic viscoelastic devices (OVDs) market. The favorable reimbursement policies for surgeries using ophthalmic viscoelastic devices (OVDs) and strategic approach of the manufacturers help them sustain the growth and expansion in the market. The collaborations, mergers and acquisitions among vendors are helping to drive the R&D activities which are expected to create the market growth. However, the availability of alternate therapies, poor healthcare infrastructure, and the lack of awareness among the healthcare fraternity may hinder the growth of the ophthalmic viscoelastic devices (OVDs) market over the forecast period.
North-America Got Significant Share
Ophthalmic Viscoelastic Devices (OVDs) Market Regional Analysis
Geographically, global ophthalmic viscoelastic devices market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North Americaophthalmic viscoelastic devices market growth driven by increase in the prevalence of eye diseases. The growing geriatric population and higher adoption of the newer technology expected to drive the market growth in the region. Falling in the second place is the European region. The growing awareness about the advanced treatments among the patient population and large disposable income is emerging markets in the region driving the market revenue growth. The Asia Pacific region is expected to be growing faster over the forecast period.
Latin America
Europe
Asia Pacific
Middle East
North America
Ophthalmic Viscoelastic Devices (OVDs) Market Segmentation
By Type
By Application
- Vitreoretinal Surgery
- Glaucoma Surgery
- Cataract Surgery
- Corneal Transplantation
By End User
- Hospitals
- Ophthalmic clinics
- Others
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa (MEA)
Frequently Asked Questions
The Ophthalmic Viscoelastic Devices (OVDs) Market is growing at a CAGR of 4.14% over the Forecast Period
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
Key Features of the Report
- The Ophthalmic Viscoelastic Devices (OVDs) Market report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
- The report covers in-detail insights about the competitors overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startups details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porters Five Force Analysis in addition to recent technology advancements and innovations in the market
| 1.Executive Summary |
| 2.Global Ophthalmic Viscoelastic Devices (OVDs) Market Introduction |
| 2.1.Global Ophthalmic Viscoelastic Devices (OVDs) Market - Taxonomy |
| 2.2.Global Ophthalmic Viscoelastic Devices (OVDs) Market - Definitions |
| 2.2.1.Type |
| 2.2.2.Application |
| 2.2.3.End User |
| 2.2.4.Route of Administration |
| 2.2.5.Region |
| 3.Global Ophthalmic Viscoelastic Devices (OVDs) Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Ophthalmic Viscoelastic Devices (OVDs) Market Analysis, 2018-2022 and Forecast 2023-2029 |
| 4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Ophthalmic Viscoelastic Devices (OVDs) Market By Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 5.1. Cohesive Ophthalmic Viscoelastic Devices (OVD) and Dispersive Ophthalmic Viscoelastic Devices (OVD) |
| 5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 6.Global Ophthalmic Viscoelastic Devices (OVDs) Market By Application, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 6.1. Vitreoretinal Surgery |
| 6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Glaucoma Surgery |
| 6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Cataract Surgery |
| 6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Corneal Transplantation |
| 6.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 7.Global Ophthalmic Viscoelastic Devices (OVDs) Market By End User, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 7.1. Hospitals |
| 7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Ophthalmology Clinics |
| 7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Others |
| 7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8.Global Ophthalmic Viscoelastic Devices (OVDs) Market By Route of Administration, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 8.1. Injection |
| 8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Nasal Spray |
| 8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 9.Global Ophthalmic Viscoelastic Devices (OVDs) Market By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia Pacific (APAC) |
| 9.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Middle East and Africa (MEA) |
| 9.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Latin America |
| 9.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 10.North America Ophthalmic Viscoelastic Devices (OVDs) Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 10.1. Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Cohesive Ophthalmic Viscoelastic Devices (OVD) and Dispersive Ophthalmic Viscoelastic Devices (OVD) |
| 10.2. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Vitreoretinal Surgery |
| 10.2.2.Glaucoma Surgery |
| 10.2.3.Cataract Surgery |
| 10.2.4.Corneal Transplantation |
| 10.3. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Hospitals |
| 10.3.2.Ophthalmology Clinics |
| 10.3.3.Others |
| 10.4. Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Injection |
| 10.4.2.Nasal Spray |
| 10.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.5.1.United States of America (USA) |
| 10.5.2.Canada |
| 11.Europe Ophthalmic Viscoelastic Devices (OVDs) Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 11.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Cohesive Ophthalmic Viscoelastic Devices (OVD) and Dispersive Ophthalmic Viscoelastic Devices (OVD) |
| 11.2. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Vitreoretinal Surgery |
| 11.2.2.Glaucoma Surgery |
| 11.2.3.Cataract Surgery |
| 11.2.4.Corneal Transplantation |
| 11.3. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Hospitals |
| 11.3.2.Ophthalmology Clinics |
| 11.3.3.Others |
| 11.4. Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Injection |
| 11.4.2.Nasal Spray |
| 11.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.5.1.Germany |
| 11.5.2.France |
| 11.5.3.Italy |
| 11.5.4.United Kingdom (UK) |
| 11.5.5.Spain |
| 11.5.6.Rest of EU |
| 12.Asia Pacific (APAC) Ophthalmic Viscoelastic Devices (OVDs) Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 12.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Cohesive Ophthalmic Viscoelastic Devices (OVD) and Dispersive Ophthalmic Viscoelastic Devices (OVD) |
| 12.2. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Vitreoretinal Surgery |
| 12.2.2.Glaucoma Surgery |
| 12.2.3.Cataract Surgery |
| 12.2.4.Corneal Transplantation |
| 12.3. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Hospitals |
| 12.3.2.Ophthalmology Clinics |
| 12.3.3.Others |
| 12.4. Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Injection |
| 12.4.2.Nasal Spray |
| 12.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.5.1.China |
| 12.5.2.India |
| 12.5.3.Australia and New Zealand (ANZ) |
| 12.5.4.Japan |
| 12.5.5.Rest of APAC |
| 13.Middle East and Africa (MEA) Ophthalmic Viscoelastic Devices (OVDs) Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 13.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Cohesive Ophthalmic Viscoelastic Devices (OVD) and Dispersive Ophthalmic Viscoelastic Devices (OVD) |
| 13.2. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Vitreoretinal Surgery |
| 13.2.2.Glaucoma Surgery |
| 13.2.3.Cataract Surgery |
| 13.2.4.Corneal Transplantation |
| 13.3. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Hospitals |
| 13.3.2.Ophthalmology Clinics |
| 13.3.3.Others |
| 13.4. Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Injection |
| 13.4.2.Nasal Spray |
| 13.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.5.1.GCC Countries |
| 13.5.2.South Africa |
| 13.5.3.Rest of MEA |
| 14.Latin America Ophthalmic Viscoelastic Devices (OVDs) Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 14.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1.Cohesive Ophthalmic Viscoelastic Devices (OVD) and Dispersive Ophthalmic Viscoelastic Devices (OVD) |
| 14.2. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1.Vitreoretinal Surgery |
| 14.2.2.Glaucoma Surgery |
| 14.2.3.Cataract Surgery |
| 14.2.4.Corneal Transplantation |
| 14.3. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1.Hospitals |
| 14.3.2.Ophthalmology Clinics |
| 14.3.3.Others |
| 14.4. Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1.Injection |
| 14.4.2.Nasal Spray |
| 14.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.5.1.Brazil |
| 14.5.2.Mexico |
| 14.5.3.Rest of LA |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 15.2.1.ohnson & Johnson ((U.S) |
| 15.2.2.Alcon Laboratories Inc. (Switzerland) |
| 15.2.3.Bausch & Lomb (U.S) |
| 15.2.4.Carl Zeiss AG (Germany) |
| 15.2.5.Rayner Company (UK) |
| 15.2.6.Bohus BioTech AB (Sweden) |
| 15.2.7.Lifecore Biomedical LLC (U.S) |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |
- Johnson & Johnson ((U.S)
- Alcon Laboratories Inc. (Switzerland)
- Bausch & Lomb (U.S)
- Carl Zeiss AG (Germany)
- Rayner Company (UK)
- Bohus BioTech AB (Sweden)
- Lifecore Biomedical LLC (U.S)